Redalpine closed its oversubscribed RAC VIII at $250 million to back about 20 European seed and Series A frontier-tech startups.

Redalpine closes $250M eighth fund for Europe

Redalpine closes $250M eighth fund for Europe

Image: AI-generated editorial illustration

Redalpine announced on November 10, 2026 that it has closed its eighth fund, RAC VIII, at $250 million. The Zurich-based venture firm said the vehicle was oversubscribed and will back around 20 early-stage European companies, mainly by leading Seed and Series A rounds.

What did Redalpine announce about RAC VIII?

Redalpine announced on November 10, 2026 that it has closed redalpine Capital VIII at $250 million, its eighth early-stage fund. The firm said the vehicle closed oversubscribed and lifted its total assets under management to more than $1.4 billion.

The new fund, known as RAC VIII, is designed to back around 20 early-stage companies across Europe, with Redalpine primarily leading Seed and Series A rounds. The firm said the strategy is centered on founders building frontier-technology companies where software meets science.

What kinds of startups will the fund back?

Redalpine said RAC VIII will target frontier technologies including fusion energy, AI, robotics and biotech. The firm also said initial investments will range from $1 million to $15 million, according to independent coverage of the fund announcement.

Redalpine said the first RAC VIII investments include Arlequin AI, calliora, Enact Intelligence, telli and Helical. Redalpine described Arlequin AI as building topological neural networks to help governments and organizations uncover hidden threats, calliora as creating an AI operating layer for hospital economics, Enact Intelligence as building a nervous system for robots, telli as building AI agents for customer conversations, and Helical as creating a virtual AI lab for pharma.

Who is behind Redalpine and how has the firm evolved?

Redalpine said Peter Niederhauser, a serial entrepreneur, and Dr. Michael Sidler, a molecular biologist, founded the firm in Zurich in 2006. The firm said half of its investment team are trained scientists, including genomists, physicists and machine learning experts.

The firm also said it reviews more than 5,000 companies each year, and that since 2023, 11 of its portfolio companies have exited. Redalpine has backed more than 100 companies over two decades, according to the firm and separate reporting from Today’s Startup News.

Today’s Startup News reported RAC VIII is 25% larger than RAC VII, which closed at $200 million in August 2024. The outlet also reported that Redalpine has offices in Zurich, Berlin and London, plus a presence in Silicon Valley.

Who supported the fund and what comes next?

Startupticker, Vestbee and Today’s Startup News reported the fund attracted backing from Aviva Investors, Flexstone Partners and Germany’s development bank KfW. LP commitment amounts were not disclosed.

Startupticker reported that Cynthia Chen of Aviva Investors said the partnership could help Aviva gain greater access to high-growth startups across the UK and Europe. The publication also reported that Redalpine began as a single early-stage fund and has grown into a multi-stage investment platform, while Rafael Hubatschek said the fund platform lets the firm back founders from Seed to scale.

Redalpine said companies backed by RAC VII have raised more than $1.1 billion in total funding since that fund’s 2024 close. With RAC VIII, the firm said it plans to continue investing in European science and software startups at the seed and Series A stages.

Sources